Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy (Q46191844)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy |
scientific article |
Statements
1 reference
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy (English)
1 reference
Jan K Damås
1 reference
Agnes Boullier
1 reference
Torgun Waehre
1 reference
Camilla Smith
1 reference
Wiggo J Sandberg
1 reference
Simone Green
1 reference
Oswald Quehenberger
1 reference
13 October 2005
1 reference
25
1 reference
12
1 reference
2567-2572
1 reference
Identifiers
1 reference